The Czech company Diana Biotechnologies has successfully deployed its ultra-sensitive automated PCR tests for COVID-19 in large laboratories. The method is now used by the Ostrava Health Institute, the Bulovka Hospital, the Pilsen University Hospital and the private GHC Genetics laboratory in Prague. It was used for more than 40,000 tests. The main advantages are high sensitivity, components made in the Czech Republic, a high degree of automation and a low price. The company, which is now negotiating with other hospitals, can guarantee a stable supply of up to 200,000 tests per month and is further increasing capacity.
Source: CIA News
Prepared by the team of CzechTrade Cairo